+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-04-30Number of Pages: 94

Hemoglobin A1c Testing Devices Market (End-use - Laboratory and Point-of-Care Testing Devices; Technologies - Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Table of Contents
 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.4 Research Methodology
1.5 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Hemoglobin A1c Testing Devices Market
2.2 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography, 2012 & 2019 (Value %)
 
Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview
3.1 Introduction and Market Definition
3.2 Market Drivers
      3.2.1 Rising Diabetic Patient Population
      3.2.2 Aging Population
      3.2.3 Proven Benefits of HbA1c Testing Leading to Rapid Adoption
3.3 Market Restraints
      3.3.1 Higher Test Cost
      3.3.2 Presence of Viable Substitutes
3.4 Market Opportunities
      3.4.1 Lucrative Market Opportunities in Emerging Economies
      3.4.2 Rapid Commercialization of Devices for Diagnosis of Diabetes
3.5 Porter’s Five Forces Analysis for the Global Hemoglobin A1c Testing Devices Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of New Entrants
      3.5.4 Threat of Substitutes
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography
3.7 Competitive Landscape
      3.7.1 Heat Map Analysis: Global Hemoglobin A1c Testing Devices Market, by Key Players
 
Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use
4.1 Overview
      4.1.1 Global Hemoglobin A1c Testing Devices Market Revenue, by End-Use, 2011 – 2019 (USD Million)
4.2 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by End-Use, 2012 & 2019 (Value %)
4.3 Laboratory Testing Devices
      4.3.1 HbA1c Laboratory Testing Devices Market Revenue, 2011 – 2019 (USD Million)
4.4 Point-of-Care (POC) Testing Devices
      4.4.1 HbA1c Point-of-Care Testing Devices Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology
5.1 Overview
      5.1.1 Global Hemoglobin A1c Testing Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Technology, 2012 & 2019 (Value %)
5.3 Ion-Exchange High Performance Liquid Chromatography (HPLC)
      5.3.1 HbA1c Ion-Exchange HPLC Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.4 Immunoassay
      5.4.1 HbA1c Immunoassay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.5 Boronate Affinity Chromatography
      5.5.1 HbA1c Boronate Affinity Chromatography Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.6 Direct Enzymatic Assay
      5.6.1 HbA1c Direct Enzymatic Assay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
5.7 Others
      5.7.1 Other HbA1c Testing Devices Technologies Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography
6.1 Overview
      6.1.1 Global Hemoglobin A1c Testing Devices Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 Rest of the World HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 7 Recommendations
7.1 Improving Measurement of HbA1c
7.2 Investing in Emerging Economies
7.3 Developing Clinical Laboratory Improvement Amendments (CLIA) Waived Tests
 
Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Alere, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 ARKRAY, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Bio-Rad Laboratories, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Chek Diagnostics (Polymer Technology Systems, Inc.)
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Danaher Corporation (Beckman Coulter)
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 EKF Diagnostics Holdings plc
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 F. Hoffmann-La Roche Ltd.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Menarini Group
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Sebia
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Siemens Healthcare
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Tosoh Corporation
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Developments
8.13 Trinity Biotech plc
      8.13.1 Company Overview
      8.13.2 Financial Overview
      8.13.3 Product Portfolio
      8.13.4 Business Strategies
      8.13.5 Recent Developments

List of Figures
 
FIG. 1 Hemoglobin A1c Testing Devices Market Segmentation
FIG. 2 Global Hemoglobin A1c Testing Devices Market, by End-Use and Technologies, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 5 Porter’s Five Forces Analysis for the Global Hemoglobin A1c Testing Devices Market
FIG. 6 Market Attractiveness Analysis of the Global Hemoglobin A1c Testing Devices Market, by Geography
FIG. 7 Heat Map Analysis: Global Hemoglobin A1c Testing Devices Market, by Key Players
FIG. 8 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by End-Use, 2012 & 2019 (Value %)
FIG. 9 HbA1c Laboratory Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 HbA1c Point-of-Care Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Technology, 2012 & 2019 (Value %)
FIG. 12 HbA1c Ion-Exchange HPLC Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 HbA1c Immunoassay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 HbA1c Boronate Affinity Chromatography Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 HbA1c Direct Enzymatic Assay Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Other HbA1c Testing Device Technologies Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 North America HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Europe HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Asia-Pacific HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Rest of the World HbA1c Testing Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 Abbott Laboratories (Immunochemistry Segment): Annual Revenue, 2010 – 2012 (USD Million)
FIG. 22 Alere, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 23 Bio-Rad Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 24 Danaher Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 EKF Diagnostics Holdings plc: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 F. Hoffmann-La Roche Ltd. (Diagnostics Business): Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Menarini Group: Consolidated Turnover, 2010 – 2012 (USD Million)
FIG. 28 Sebia: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Siemens Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 Tosoh Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 Trinity Biotech plc: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Hemoglobin A1c Testing Devices Market
TABLE 3 Comparing DCCT-HbA1c and IFCC-HbA1c Results
TABLE 4 Worldwide Diabetic Population, by Region, 2013 & 2035 (Million Individuals)
TABLE 5 Top 10 Countries/Territories by Diabetes Prevalence (20 years to 79 years), 2013 & 2035
TABLE 6 Global Hemoglobin A1c Testing Devices Market Revenue, by End-Use, 2011 – 2019 (USD Million)
TABLE 7 Global Hemoglobin A1c Testing Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 8 Global Hemoglobin A1c Testing Devices Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Top 5 European Countries, by Number of Diabetes Cases, 2012 (Million)


 
 
Back To Top